Average (standard deviation) cumulative 6MP dose intensity, expressed as a percentage of the protocol-specified dosage of 6MP, evaluated at 30, 60, 90, and 120 weeks from the start of continuation therapy in those who remained in continuous remission (□) and those who eventually failed (▪). The numbers of patients at each of the four time points are 165, 156, 150, and 142, respectively.